Cytek Biosciences, Inc. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cytek Biosciences, Inc. annual/quarterly Return On Equity history and growth rate from 2020 to 2023.
  • Cytek Biosciences, Inc. Return On Equity for the quarter ending June 30, 2023 was -1.39 %, a 116% decline year-over-year.
  • Cytek Biosciences, Inc. annual Return On Equity for 2023 was -2.93 %, a 590% decline from 2022.
  • Cytek Biosciences, Inc. annual Return On Equity for 2022 was 0.6 %, a 61.4% decline from 2021.
  • Cytek Biosciences, Inc. annual Return On Equity for 2021 was 1.55 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -2.93 -3.53 -590% Jan 1, 2023 Dec 31, 2023
2022 0.6 -0.95 -61.4% Jan 1, 2022 Dec 31, 2022
2021 1.55 +66.1 Jan 1, 2021 Dec 31, 2021
2020 -64.6 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.